Skip to main content
OpenTrials

Clinical trial condition

Rectal Cancer Stage III

Explore clinical trials studying Rectal Cancer Stage III. Study availability and eligibility vary by location and protocol.

18 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Rectal Cancer Stage III trial results

Completed

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

NCT03602079

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +129 more
Locations
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Beth Israel Deaconess Medical Center Cancer Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Clinical Research Alliance, Inc. Lake Success, New York, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

NCT04503694

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • Chirec Delta Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • UZAntwerpen Edegem, Belgium
View Trial Details
Active, Not Recruiting

Short RT Versus RCT,Followed by Chemo.and Organ Preservation for Interm and High-risk Rectal Cancer Patients

NCT04246684

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Clincal Center Esslingen Esslingen am Neckar, Baden-Wurttemberg, Germany
  • University Clinic Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • University Clinic Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Clinic Ostlab, Staufenclinic Schwaeb.Gmuend, Mutlangen Mutlangen, Baden-Wurttemberg, Germany
View all 76 locations
View Trial Details

Related conditions